SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001590750-22-000009
Filing Date
2022-08-15
Accepted
2022-08-15 07:19:34
Documents
68
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q mgen-20220630.htm   iXBRL 10-Q 1573779
2 EX-10.2 ex102_bi-watchfactoryxviri.htm EX-10.2 109031
3 EX-10.3 ex10_3amendedandrestated20.htm EX-10.3 234520
4 EX-31.1 ex311_2022-06.htm EX-31.1 11319
5 EX-31.2 ex312_2022-06.htm EX-31.2 13081
6 EX-32.1 ex321_2022-06.htm EX-32.1 9894
12 image_0.jpg GRAPHIC 95182
13 image_1.jpg GRAPHIC 2683
14 image_3.jpg GRAPHIC 92217
15 image_4.jpg GRAPHIC 110
16 image_5.jpg GRAPHIC 116410
  Complete submission text file 0001590750-22-000009.txt   7549100

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mgen-20220630.xsd EX-101.SCH 41063
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT mgen-20220630_cal.xml EX-101.CAL 52732
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mgen-20220630_def.xml EX-101.DEF 252799
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mgen-20220630_lab.xml EX-101.LAB 568817
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mgen-20220630_pre.xml EX-101.PRE 365647
62 EXTRACTED XBRL INSTANCE DOCUMENT mgen-20220630_htm.xml XML 1031763
Mailing Address 203 CRESCENT STREET BLDG. 17, SUITE 102B WALTHAM MA 02453
Business Address 203 CRESCENT STREET BLDG. 17, SUITE 102B WALTHAM MA 02453 617.272.4600
Viridian Therapeutics, Inc.\DE (Filer) CIK: 0001590750 (see all company filings)

IRS No.: 471187261 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36483 | Film No.: 221162312
SIC: 8071 Services-Medical Laboratories